View Older Stories

Dec 9, 2025 04:34AM TD Cowen on Syndax Pharmaceuticals (SNDX): 'We found the updates at ASH generally encouraging'

Dec 8, 2025 06:50AM Syndax presents real-world data for menin inhibitor at ASH conference

Nov 4, 2025 09:31AM Stifel Reiterates Buy Rating on Syndax Pharmaceuticals (SNDX)

Nov 4, 2025 04:21AM Syndax Pharmaceuticals (SNDX) PT Raised to $27 at Goldman Sachs

Nov 3, 2025 04:05PM Syndax Pharmaceuticals (SNDX) Tops Q3 EPS by 3c

Nov 3, 2025 09:09AM Syndax receives 23 abstracts accepted for ASH 2025 meeting

Oct 27, 2025 07:48AM Syndax Pharmaceuticals' (SNDX) Revuforj Expansion a Long-term Growth Lever- Stifel

Oct 24, 2025 01:08PM FDA approves Syndax Pharmaceuticals' (SNDX) revumenib for myeloid leukemia

Oct 24, 2025 12:57PM Syndax Pharmaceuticals (SNDX) halted, news pending

Oct 16, 2025 06:39AM H.C. Wainwright Assumes Syndax Pharmaceuticals (SNDX) at Buy

Oct 16, 2025 06:16AM BofA Shuffles Endeavor List Names

Sep 19, 2025 07:00AM NCCN adds Syndax's Revuforj to leukemia treatment guidelines

Sep 10, 2025 01:59AM Stifel Resumes Syndax Pharmaceuticals (SNDX) at Buy

Sep 4, 2025 05:41AM Guggenheim Starts Syndax Pharmaceuticals (SNDX) at Buy

Aug 6, 2025 08:01AM B.Riley Assumes Syndax Pharmaceuticals (SNDX) at Buy

Aug 5, 2025 11:15AM Syndax Pharmaceuticals (SNDX) PT Raised to $51 at Citi, Opens 90d Catalyst Watch

Aug 5, 2025 06:26AM Syndax Pharmaceuticals (SNDX) PT Raised to $56 at BTIG

Aug 5, 2025 05:12AM Syndax Pharmaceuticals (SNDX) PT Raised to $20 at Goldman Sachs

Aug 4, 2025 04:55PM Syndax Pharmaceuticals (SNDX) Tops Q2 EPS by 18c

Jul 21, 2025 03:36PM Syndax Pharmaceuticals (SNDX) 4300 contracts of January 12.5 calls trade

Jul 21, 2025 10:58AM Increasing unusual call option volume: OPEN IVZ VERI ROIV URNM CX ABAT UAA SNDX

Jul 15, 2025 06:21AM Syndax Pharmaceuticals (SNDX) PT Lowered to $35 at UBS

Jul 10, 2025 02:25AM Goldman Sachs Starts Syndax Pharmaceuticals (SNDX) at Buy

Jun 24, 2025 04:02PM Syndax Pharmaceuticals (SNDX) announces FDA Priority Review of sNDA for Revuforj

Jun 12, 2025 12:03PM Syndax Pharmaceuticals (SNDX) announces data from BEAT AML trial evaluating revumenib

Jun 12, 2025 07:00AM Syndax Pharmaceuticals (SNDX) Presents New Revuforj Data in Relapsed/Refractory mNPM1 and NUP98r Acute Leukemia from AUGMENT-101 Trial

May 25, 2025 03:00PM Biotech stocks Q1 earnings review

May 6, 2025 07:09AM Syndax Pharmaceuticals (SNDX) PT Raised to $17 at Scotiabank

May 6, 2025 05:40AM Syndax Pharmaceuticals (SNDX) PT Raised to $26 at BofA Securities

May 5, 2025 04:29PM Syndax Pharmaceuticals (SNDX) Tops Q1 EPS by 26c

Mar 10, 2025 04:42AM Increasing unusual option volume: PEG CYH PRGO SNDX VSCO XLI AMPL

Mar 4, 2025 06:42AM H.C. Wainwright Reiterates Buy Rating on Syndax Pharmaceuticals (SNDX)

Mar 4, 2025 05:46AM BTIG Reiterates Buy Rating on Syndax Pharmaceuticals (SNDX)

Mar 4, 2025 04:55AM Syndax Pharmaceuticals (SNDX) PT Lowered to $31 at Goldman Sachs

Mar 3, 2025 01:06PM Syndax Pharmaceuticals (SNDX) PT Lowered to $29 at B.Riley

Feb 17, 2025 05:41PM Kuehn Law Encourages Investors of Syndax Pharmaceuticals, Inc. to Contact Law Firm

Jan 6, 2025 12:31PM Jefferies Reiterates Buy Rating on Syndax Pharmaceuticals (SNDX)

Dec 28, 2024 01:38PM Kuehn Law Encourages Investors of Syndax Pharmaceuticals, Inc. to Contact Law Firm

Nov 19, 2024 11:00AM JPM just added these stocks to its Analyst Focus List - giving one 148% upside

Nov 18, 2024 07:59AM TD Cowen Reiterates Buy Rating on Syndax Pharmaceuticals (SNDX)

Nov 18, 2024 06:54AM Syndax Pharmaceuticals (SNDX) PT Raised to $51 at H.C. Wainwright

Nov 13, 2024 07:20AM Syndax Pharmaceuticals (SNDX) PT Lowered to $18 at Scotiabank

Nov 13, 2024 06:53AM Syndax Pharmaceuticals (SNDX) PT Raised to $49 at H.C. Wainwright

Nov 13, 2024 05:46AM Syndax Pharmaceuticals (SNDX) PT Lowered to $31 at Goldman Sachs

Nov 12, 2024 07:06AM Syndax Pharmaceuticals (SNDX) Announces Positive Pivotal Topline Results from Relapsed or Refractory mNPM1 AML Cohort in AUGMENT-101 Trial of Revumenib

Nov 6, 2024 06:48AM Syndax Pharmaceuticals (SNDX) PT Raised to $47 at H.C. Wainwright

Nov 5, 2024 04:04PM Syndax Pharmaceuticals (SNDX) Tops Q3 EPS by 9c, provides guidance

Nov 4, 2024 04:02PM Syndax Pharmaceuticals (SNDX) and Royalty Pharma (RPRX) Enter $350M Royalty Funding Agreement for Niktimvo

Oct 24, 2024 03:22AM UBS Starts Syndax Pharmaceuticals (SNDX) at Buy

Oct 9, 2024 06:22AM B.Riley Reiterates Buy Rating on Syndax Pharmaceuticals (SNDX)

View Older Stories